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The generation of hybridomas and monoclonal ntibodies i certainly 
one of the most powerful inventions of the past 20 years. Monoclonal 
antibodies are useful reagents for the identification and purification of 
molecules and cells, both in basic research and in many areas of clincial 
medicine. Among numerous other applications, they have raised new 
hopes for Paul Ehrlich's old idea that targeted antibodies can be used 
as 'magic bullets' against infectious diseases and cancer. For inventing 
monoclonal antibodies, Georges Kahler (1946-1995) and C6sar 
Milstein received the Nobel Prize in Physiology and Medicine in 1984. 
Monoclonal antibodies have an important and wide-ranging role in 
most areas of biomedical research and this volume is among the first 
to attempt to combine both the technical and clinical aspects of the 
subject. Monoclonal antibodies have continued to provide highly 
specific and versatile reagents with which to identify, analyze, 
quantitate and manipulate molecules, both in solution and in the solid 
phase, as for instance on the cell surface. The aim of the book is to 
provide a unique source of information concerning the production of 
antibodies, both by hybridoma nd other cellular techniques, as well 
as by more recent techniques based on molecular biology. These 
technical descriptions are followed by discussions of the different 
analytic, diagnostic and therapeutic applications in clinical medicine 
including histopathology, oncology, transplantation, infectious 
diseases, rheumatology, haematology and dermatology. The initial 
chapters include a brief introduction tothe basic aspects of the immune 
response to generate antibodies (Chapter 1 by M.A. Ritter), the use of 
cellular and molecular techniques for the generation of mouse and 
human monoclonal ntibodies (Chapter 2by H.M. Ladyman and M.A. 
Ritter; Chapter 5by A. Sa'adu and A. ZumIa) as well as the production 
of antibodies by phage display techniques (Chapter 7 by A.J.T. 
George), genetic manipulation ofmonoclonal ntibodies (Chapter 8by 
N.S. Courtenay-Luck), the generation and applications of bispecific 
monoclonal ntibodies (Chapter 6by S. Songsivilai and P.J. Lachman), 
mapping of epitopes recognized by antibodies and the generation of 
peptide antibodies (Chapter 4 by K.M. Price), and the use of 
monoclonal ntibodies innovel and enhanced diagnostic mmunoassay 
systems (Chapter 9 by D.B. Cook and C.H. Self). To complete this 
aspect of the book, Chapter 3 by R.J. Morris provides an important 
and 'user-friendly' introduction to antigen-antibody interactions and 
how affinity and kinetics affect assay design and antibody selection 
procedures. The second part of the book contains a series of chapters 
(Chapters 10 to 16) covering most of the many clinical areas in which 
monoclonal ntibodies are currently used, both for routine applications 
as well as for experimental purposes. Chapters 10A (by A. Colfor and 
P.A. Hall) and 10B (by A. Bamias and A.A. Epenetos) discuss the uses 
of monoclonal ntibodies in oncology, in diagnostic pathology and for 
in vivo targeting for immunoscintigraphy and therapy of human 
malignancies. As pointed out before, the idea of targeting human 
tumors with antibodies i by no means a new one, and monoclonal 
antibodies have already now been tested in connection with diagnosis 
and/or therapy in vivo for more than 15 years but due to limited success 
have so far not been established asa routine in the clinic. Several more 
recent developments, e pecially in the recombinant DNA area and in 
the generation of human antibodies, might raise new hopes that after 
all the 'magic bullets' might be within reach in a foreseeable future. 
Chapters 11A (by T.G. Wreghitt and J.J. Gray) and 11B (by J. Cohen) 
discuss the applications ofmonoclonal ntibodies inthe important area 
of infectious diseases, for diagnosis and in prophylaxis and therapy~ 
respectively. Monoclonal antibodies have already found important 
applications for diagnosis of infectious diseases, but similarly to the 
cancer area in vivo applications have been more problematic as 
exemplified by the variable results obtained in treatment of Gram- 
negative sepsis with monoclonal antibodies. A further important 
application area is the use of monoclonal ntibodies inconnection with 
transplantation a d for immunosuppression, where the immunohis- 
tological applications are discussed inChapter 12A (by M.L. Rose), the 
experimental uses of monoclonal ntibodies in Chapter 12B (by N.M. 
Parish and A. Cooke), prophylaxis and treatment og graft-versus-host 
disease after bone marrow transplantation i  Chapter 12C (by 
L. Bostr6m and O. Ringd~n), and the clinical uses in organ 
transplantation i  Chapter 12D (by M. Giral et al.). The use of 
monoclonal antibodies in further clinical areas are discussed in the 
following three chapters: monoclonal antibodies and the skin (Chap- 
ter 13 by A.C. Chu and E. Tsele), monoclonal ntibodies inendocrinol- 
ogy (Chapter 14 by E. Hillhouse and C.H. Self), and finally a discus- 
sion of monoclonal antibodies in rheumatology (Chapter 15 by J.D. 
Isaacs). A final technical appendix (Chapter 16 by H.M. Ladyman 
and M.A. Ritter) summarizes the basic methods and recipes 
used in the generation, production and characterization of 
mouse monoclonal antibodies (introduced in Chapter 2) and in ad- 
dition gives a number of practical hints which are useful for the 
beginner in this field. A similar technical appendix containing the basic 
protocols for conjugation of peptide antigens i included separately in
Chapter 4. 
All these chapters include xtensive bibliographies which makes this 
book an excellent source for primary reference material. 
All in all the editors and the individual authors have succeeded in
realizing their intentions in producing yet another volume on the 
principles, methods and uses of monoclonal antibodies as well as 
recombinant antibodies. The book is extremely well suited as an 
introduction to monoclonal antibodies for clinicians from different 
areas of clinical medicine. After reading the book, it should be possible 
for even beginners in the field to raise their own monoclonal ntibodies 
and to obtain some appreciation of the advantages and disadvantages 
of these reagents. Even if some readers do not go on to produce their 
own antibodies, nearly everybody in some area of biomedical science 
are confronted with monoclonal antibodies as reagents and for this 
reason it is highly relevant with a single source for information on the 
advantages and potential pitfalls of using these unique reagents. The 
book is well organized though it is necessary for the reader to get 
acquainted with how its put together to use it to its full advantage. A 
final plea is caused by the abbreviation 'mabs' for monoclonal 
antibodies which is used throughout this volume: it is high time for a 
consensus in this area, we already have 'MAbs' and 'mAbs', what is 
next? 
Jesper Zeuthen 
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This volume is another fine addition to The Practical Approach Series 
(series editors D. Rickwood and B.D. Hames). The book lives up to the 
consistently high quality of this series whose place is in the laboratory 
rather than in the library. The specificity by which antibodies recognize 
and bind to proteins and peptides has been a major subject of 
immunochemical research and the use of peptides to produce 
antibodies, to affinity-purify antibodies, and to map epitopes has been 
essential in advancing our comprehension of antigen-antibody 
reactions. The topics covered span a wide range of techniques helpful 
to the use of peptides in the study of antibodies. After a short 
introductory resum6 (G.B. Wisdom) of the application of peptides as 
antigens and immunogens follows the only chapter of the book which 
is of a more theoretical nature: 'Epitope prediction from the primary 
structure of proteins' (J.-L. Pellequer, E. Westhof, M.H.V. van 
Regenmortel). The large body of information about epitopes on 
proteins of known three-dimensional structure combined with results 
from epitope mapping with peptides have been used to develop 
prediction methods for antigenic sites on proteins. The prediction 
algorithms are valuable to design peptides having a higher probability 
of inducing protein-reactive antibodies and, thus, are useful in the 
production of antibodies against proteins whose sequence has been 
derived only from DNA or which are otherwise unavailable for 
